These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 224827)

  • 21. Dendritic cell-based vaccines in treating recurrent herpes labialis: Results of pilot clinical study.
    Leplina O; Starostina N; Zheltova O; Ostanin A; Shevela E; Chernykh E
    Hum Vaccin Immunother; 2016 Dec; 12(12):3029-3035. PubMed ID: 27635861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural cytotoxic cell activity linked to time of recurrence of herpes labialis.
    Rola-Pleszczynski M; Lieu H
    Clin Exp Immunol; 1984 Jan; 55(1):224-8. PubMed ID: 6319058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levamisole in patients with recurrent herpes infection.
    Jose DG; Minty CC
    Med J Aust; 1980 Oct; 2(7):390-4. PubMed ID: 7005629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon gamma production by herpes simplex virus antigen-specific T cell clones from patients with recurrent herpes labialis.
    Cunningham AL; Nelson PA; Fathman CG; Merigan TC
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():249-58. PubMed ID: 2981967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
    O'Reilly RJ; Chibbaro A; Anger E; Lopez C
    J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immunity to herpes virus type-1 in patients with recurrent corneal herpes simplex.
    Hammer H; Dobozy A
    Acta Ophthalmol (Copenh); 1980 Apr; 58(2):161-6. PubMed ID: 6249065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical evaluation of the use of levamisole in treatment of recurrent labial herpes simplex].
    Machado JA
    Ars Curandi Odontol; 1979 Nov; 6(8):32-5. PubMed ID: 296686
    [No Abstract]   [Full Text] [Related]  

  • 28. Viral inhibition of lymphocyte proliferative responsiveness in patients suffering from recurrent lesions caused by herpes simplex virus.
    Wainberg MA; Portnoy JD; Clecner B; Hubschman S; Lagacé-Simard J; Rabinovitch N; Remer Z; Mendelson J
    J Infect Dis; 1985 Sep; 152(3):441-8. PubMed ID: 2993440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of correlation between HLA-B35 resistance against herpes labialis and antibody titers to HSV-1.
    Gallina G; Cumbo V; Messina P; Caprera V; Lio D; Caruso C
    Oral Surg Oral Med Oral Pathol; 1989 Aug; 68(2):167-70. PubMed ID: 2550869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of complement fixation and Tzanck smear tests for the diagnosis of herpes labialis].
    Yurdakul C; Ozcan K; Aksungur L; Köksal F
    Mikrobiyol Bul; 1986 Apr; 20(2):84-90. PubMed ID: 3022117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Specific immunostimulation in the therapy of recurrent herpes simplex type I or II].
    Veneroni G; Calixte C; Bozzo Costa E; Germogli R
    Boll Ist Sieroter Milan; 1987; 66(6):427-34. PubMed ID: 2839208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes simplex and herpes genitalis viruses in etiology of some human cancers.
    Sabin AB; Tarro G
    Proc Natl Acad Sci U S A; 1973 Nov; 70(11):3225-9. PubMed ID: 4361685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Levamisole - a new treatment for two old problems: recurrent aphthous ulceration and recurrent labial herpes simplex].
    Machado JA
    Rev Assoc Paul Cir Dent; 1981; 35(1):20-6. PubMed ID: 6943614
    [No Abstract]   [Full Text] [Related]  

  • 34. Tuberculin conversion and leukocyte migration inhibition test after BCG vaccination in newborn infants.
    Faridi M; Kaur S; Krishnamurthy S; Kumari P
    Hum Vaccin; 2009 Oct; 5(10):690-5. PubMed ID: 19855160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A placebo-controlled trial of thymic hormone treatment of recurrent herpes simplex labialis infection in immunodeficient host: results after a 1-year follow-up.
    Aiuti F; Sirianni MC; Fiorilli M; Paganelli R; Stella A; Turbessi G
    Clin Immunol Immunopathol; 1984 Jan; 30(1):11-8. PubMed ID: 6321073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative titers of antibodies to individual polypeptide antigens of herpes simplex virus type 1 in human sera.
    Eberle R; Mou SW
    J Infect Dis; 1983 Sep; 148(3):436-44. PubMed ID: 6311910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent herpes infections and levamisole.
    Queiroz Carvalho CA; Kinue Otuki T; Elizabeth Poli M; Nogueira JL; Guerrero J
    Rev Latinoam Microbiol; 1976; 18(4):225-6. PubMed ID: 801844
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunostimulatory function of herpes simplex virus isolates from patients with frequent herpes labialis and a deficiency in immune-specific interferon production.
    Klieman RL; Green JA; Spruance SL
    J Med Virol; 1985 Jul; 16(3):289-96. PubMed ID: 2993499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cellular immunity reactions in herpetic eye infection].
    Slepova OS; Murav'eva TV; Zaĭtseva NS
    Vopr Virusol; 1978; (4):452-8. PubMed ID: 219617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind, controlled trial of levamisole in the treatment of recurrent herpes labialis.
    Russell AS; Brisson E; Grace M
    J Infect Dis; 1978 May; 137(5):597-600. PubMed ID: 351073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.